We are live on ! Find out more
AMED

Amedisys
AMED

Delisted

AMED was delisted on the 14th of August, 2025.

Back to rankings

328 hedge funds and large institutions have $5.19B invested in Amedisys in 2022 Q1 according to their latest regulatory filings, with 64 funds opening new positions, 127 increasing their positions, 91 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

40% more repeat investments, than reductions

Existing positions increased: 127 | Existing positions reduced: 91

14% more first-time investments, than exits

New positions opened: 64 | Existing positions closed: 56

10% more capital invested

Capital invested by funds: $4.72B → $5.19B (+$473M)

3.11% more ownership

Funds ownership: 89.76% → 92.87% (+3.1%)

1% more funds holding

Funds holding: 324 → 328 (+4)

8% more call options, than puts

Call options by funds: $57.2M | Put options by funds: $52.8M

Holders
328
Holders Change
+4
Holders Change %
+1.23%
% of All Funds
5.17%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
64
Increased
127
Reduced
91
Closed
56
Calls
$57.2M
Puts
$52.8M
Net Calls
+$4.4M
Net Calls Change
-$6.63M

Top Buyers

1
Mackenzie Financial
Mackenzie Financial
Ontario, Canada
+$57.7M
2
JP Morgan Chase
JP Morgan Chase
New York
+$45.5M
3
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$33M
4
Millennium Management
Millennium Management
New York
+$32M
5
FCM
Frontier Capital Management
Massachusetts
+$25.2M

Top Sellers

1
Viking Global Investors
Viking Global Investors
Connecticut
-$63.3M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$49M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$33.1M
4
Ameriprise
Ameriprise
Minnesota
-$30.5M
5
CG
Carmignac Gestion
France
-$25.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
26
D.E. Shaw & Co
New York
$52.1M -$33.1M -221,656 -42%
Westfield Capital Management
27
Westfield Capital Management
Massachusetts
$50.7M -$611K -4,092 -1%
Norges Bank
28
Norges Bank
Norway
$46.6M -$4.32M -28,944 -10%
EAM
29
Eagle Asset Management
Florida
$41.2M +$555K +3,718 +2%
Millennium Management
30
Millennium Management
New York
$38.3M +$32M +214,360 +2,622%
Ensign Peak Advisors
31
Ensign Peak Advisors
Utah
$37M -$5.87M -39,258 -15%
Amundi
32
Amundi
France
$36.9M +$8.13M +54,443 +33%
Bank of America
33
Bank of America
North Carolina
$36.2M +$3.5M +23,445 +13%
Envestnet Asset Management
34
Envestnet Asset Management
Illinois
$24.7M +$1.38M +9,223 +7%
Wells Fargo
35
Wells Fargo
California
$24.7M +$430K +2,880 +2%
First Trust Advisors
36
First Trust Advisors
Illinois
$24.3M -$1.61M -10,777 -7%
SBH
37
Segall Bryant & Hamill
Illinois
$21.9M +$2.06M +13,810 +12%
VOYA Investment Management
38
VOYA Investment Management
Georgia
$21.8M +$14.9M +99,701 +369%
Morgan Stanley
39
Morgan Stanley
New York
$18.2M -$7.54M -50,463 -32%
BPC
40
Banque Pictet & Cie
Switzerland
$17.9M +$5.31M +35,525 +52%
Fidelity Investments
41
Fidelity Investments
Massachusetts
$17.5M +$13.9M +93,148 +1,116%
Fuller & Thaler Asset Management
42
Fuller & Thaler Asset Management
California
$17.2M +$77.1K +516 +0.5%
Canada Life
43
Canada Life
Manitoba, Canada
$17.1M +$12.3M +82,289 +499%
Retirement Systems of Alabama
44
Retirement Systems of Alabama
Alabama
$15.9M +$12.8K +86 +0.1%
TIM
45
Thornburg Investment Management
New Mexico
$15.6M -$787K -5,266 -5%
PAMP
46
Polar Asset Management Partners
Ontario, Canada
$15.2M +$4.44M +29,700 +51%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$15.2M -$23.5K -157 -0.2%
Voloridge Investment Management
48
Voloridge Investment Management
Florida
$14.8M -$7.67M -51,361 -37%
Victory Capital Management
49
Victory Capital Management
Texas
$14M +$6.15M +41,192 +98%
N
50
Nuveen
North Carolina
$13.6M +$16K +107 +0.1%
1
2
3 4 5

AMED Hedge Fund Activity: Q1 2022 in Review

328 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q1 2022, worth a combined $5.19B — up 10% from $4.72B a quarter earlier.

Buyers outnumbered sellers: 64 funds opened new AMED positions and 56 closed out — a net gain of 8 holders — while 127 added to existing stakes and 91 trimmed.

The largest buyer was Mackenzie Financial, adding an estimated $57.7M. The largest seller was Viking Global Investors, exiting entirely with an estimated $63.3M sold.

  • 328 institutional investors held Amedisys (AMED) as of Q1 2022, up from 324 in Q4 2021.
  • Funds reported $5.19B of Amedisys stock for Q1 2022, up 10% quarter-over-quarter.
  • 64 funds opened new Amedisys positions in Q1 2022 and 56 closed out, a net change of +8 holders.
  • The largest Amedisys buyer in Q1 2022 was Mackenzie Financial, an estimated $57.7M added.
  • The largest Amedisys seller in Q1 2022 was Viking Global Investors, an estimated $63.3M sold.

Based on aggregated 13F filings for Q1 2022.